MEDICAL DEVICE AUTHORITY APPROVES TRIPLEX INTERNATIONAL BIOSCIENCES' SARS-COV-2 ANTIGEN RAPID TEST KIT (SALIVA) FOR SELF-TEST IN MALAYSIA

MDA approved- TIB Covid-19 Saliva Self Test. Highest Sensitivity, accuracy and specificity, evaluated by IMR, Malaysia

KUALA LUMPUR, Malaysia, Oct 5 (Bernama) -- Universal Therapeutics, a multinational pharmaceutical and biotech company based in Malaysia, today announced that the Medical Device Authority of Malaysia (MDA) has approved the SARS-CoV-2 Antigen Rapid Test Kit (Saliva) for self-testing.

Manufactured by Triplex International Biosciences (China), the easy-to-use Rapid Test Kit can quickly detect the possibility of a COVID-19 infection, with a sensitivity of 100% specificity of 100% and accuracy of 100%. The test kit works by detecting the presence of the coronavirus nucleocapsid protein in saliva samples. Infants under the age of two are not recommended to use this test kit.

“With the relentless spread of COVID-19, new variants and the huge strain on public healthcare systems, this easy-to-use saliva self-test kit meets the demand for a quick, affordable and accurate way to detect the virus, thereby aiding virus containment efforts,” said Sidney Soares, Chief Executive Officer, Universal Therapeutics.

The kit will be made available through Universal Therapeutics’ network of hospitals, medical facilities, medical institutions and pharmacies.

MEDICAL DEVICE AUTHORITY APPROVES TRIPLEX INTERNATIONAL BIOSCIENCES' SARS-COV-2 ANTIGEN RAPID TEST KIT (SALIVA) FOR SELF-TEST IN MALAYSIA